# Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

> **NCT01038869** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 20 (actual)

## Conditions studied

- Acne Vulgaris
- Post Inflammatory Hyperpigmentation

## Interventions

- **DRUG:** Azelaic acid

## Key facts

- **NCT ID:** NCT01038869
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038869, "Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01038869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*